Halozyme Therapeutics shares owned by Asset Management Investors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Asset Management Investors
from 13F filings
Historical chart of Asset Management Investors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Asset Management Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Asset Management Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $343k | 6.0k | 57.24 |
| 2024-06-30 | $314k | 6.0k | 52.36 |
| 2024-03-31 | $325k | 8.0k | 40.68 |
More positions owned by Asset Management Investors
View all positions for Asset Management Investors